IMTX
Price
$9.40
Change
+$0.67 (+7.67%)
Updated
Oct 3 closing price
Capitalization
1.14B
43 days until earnings call
ZVRA
Price
$9.75
Change
+$0.44 (+4.73%)
Updated
Oct 3 closing price
Capitalization
547.32M
30 days until earnings call
Interact to see
Advertisement

IMTX vs ZVRA

Header iconIMTX vs ZVRA Comparison
Open Charts IMTX vs ZVRABanner chart's image
Immatics
Price$9.40
Change+$0.67 (+7.67%)
Volume$1.4M
Capitalization1.14B
Zevra Therapeutics
Price$9.75
Change+$0.44 (+4.73%)
Volume$1.13M
Capitalization547.32M
IMTX vs ZVRA Comparison Chart in %
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMTX vs. ZVRA commentary
Oct 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMTX is a Buy and ZVRA is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Oct 06, 2025
Stock price -- (IMTX: $9.40 vs. ZVRA: $9.75)
Brand notoriety: IMTX and ZVRA are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMTX: 172% vs. ZVRA: 61%
Market capitalization -- IMTX: $1.14B vs. ZVRA: $547.32M
IMTX [@Biotechnology] is valued at $1.14B. ZVRA’s [@Biotechnology] market capitalization is $547.32M. The market cap for tickers in the [@Biotechnology] industry ranges from $103.4B to $0. The average market capitalization across the [@Biotechnology] industry is $2.05B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMTX’s FA Score shows that 0 FA rating(s) are green whileZVRA’s FA Score has 1 green FA rating(s).

  • IMTX’s FA Score: 0 green, 5 red.
  • ZVRA’s FA Score: 1 green, 4 red.
According to our system of comparison, ZVRA is a better buy in the long-term than IMTX.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMTX’s TA Score shows that 6 TA indicator(s) are bullish while ZVRA’s TA Score has 4 bullish TA indicator(s).

  • IMTX’s TA Score: 6 bullish, 4 bearish.
  • ZVRA’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, IMTX is a better buy in the short-term than ZVRA.

Price Growth

IMTX (@Biotechnology) experienced а +22.08% price change this week, while ZVRA (@Biotechnology) price change was -0.20% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.93%. For the same industry, the average monthly price growth was +13.10%, and the average quarterly price growth was +80.18%.

Reported Earning Dates

IMTX is expected to report earnings on Nov 18, 2025.

ZVRA is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+4.93% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMTX($1.14B) has a higher market cap than ZVRA($547M). IMTX YTD gains are higher at: 32.208 vs. ZVRA (16.906). ZVRA has higher annual earnings (EBITDA): 36.4M vs. IMTX (-58.05M). IMTX has more cash in the bank: 478M vs. ZVRA (203M). IMTX has less debt than ZVRA: IMTX (17.1M) vs ZVRA (62.3M). IMTX has higher revenues than ZVRA: IMTX (130M) vs ZVRA (62M).
IMTXZVRAIMTX / ZVRA
Capitalization1.14B547M209%
EBITDA-58.05M36.4M-159%
Gain YTD32.20816.906191%
P/E Ratio27.61N/A-
Revenue130M62M210%
Total Cash478M203M235%
Total Debt17.1M62.3M27%
FUNDAMENTALS RATINGS
IMTX vs ZVRA: Fundamental Ratings
IMTX
ZVRA
OUTLOOK RATING
1..100
4234
VALUATION
overvalued / fair valued / undervalued
1..100
72
Overvalued
80
Overvalued
PROFIT vs RISK RATING
1..100
93100
SMR RATING
1..100
9588
PRICE GROWTH RATING
1..100
3645
P/E GROWTH RATING
1..100
6222
SEASONALITY SCORE
1..100
n/a50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

IMTX's Valuation (72) in the null industry is in the same range as ZVRA (80). This means that IMTX’s stock grew similarly to ZVRA’s over the last 12 months.

IMTX's Profit vs Risk Rating (93) in the null industry is in the same range as ZVRA (100). This means that IMTX’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's SMR Rating (88) in the null industry is in the same range as IMTX (95). This means that ZVRA’s stock grew similarly to IMTX’s over the last 12 months.

IMTX's Price Growth Rating (36) in the null industry is in the same range as ZVRA (45). This means that IMTX’s stock grew similarly to ZVRA’s over the last 12 months.

ZVRA's P/E Growth Rating (22) in the null industry is somewhat better than the same rating for IMTX (62). This means that ZVRA’s stock grew somewhat faster than IMTX’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
IMTXZVRA
RSI
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
80%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
80%
Momentum
ODDS (%)
Bullish Trend 3 days ago
74%
Bullish Trend 3 days ago
84%
MACD
ODDS (%)
Bullish Trend 3 days ago
81%
Bullish Trend 3 days ago
76%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
78%
Bearish Trend 3 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
76%
Bullish Trend 3 days ago
78%
Advances
ODDS (%)
Bullish Trend 5 days ago
77%
Bullish Trend 10 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
79%
Bearish Trend 4 days ago
77%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
88%
Bearish Trend 3 days ago
81%
Aroon
ODDS (%)
Bullish Trend 3 days ago
74%
Bearish Trend 3 days ago
85%
View a ticker or compare two or three
Interact to see
Advertisement
IMTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
ZVRA
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
GIIZX14.710.10
+0.68%
GuideStone Funds Intl Eq Idx Investor
RALOX10.750.04
+0.37%
Lazard Real Assets Open
REACX26.500.07
+0.26%
American Century Real Estate Inv
FDTTX27.520.06
+0.22%
Fidelity Advisor Capital Development A
RYSPX101.520.01
+0.01%
Rydex S&P 500 H

IMTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMTX has been loosely correlated with IDYA. These tickers have moved in lockstep 52% of the time. This A.I.-generated data suggests there is some statistical probability that if IMTX jumps, then IDYA could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMTX
1D Price
Change %
IMTX100%
+7.67%
IDYA - IMTX
52%
Loosely correlated
+1.62%
IMNM - IMTX
49%
Loosely correlated
+7.93%
XNCR - IMTX
49%
Loosely correlated
-0.42%
OCUL - IMTX
48%
Loosely correlated
+3.16%
NRIX - IMTX
48%
Loosely correlated
+3.30%
More

ZVRA and

Correlation & Price change

A.I.dvisor indicates that over the last year, ZVRA has been loosely correlated with KALV. These tickers have moved in lockstep 37% of the time. This A.I.-generated data suggests there is some statistical probability that if ZVRA jumps, then KALV could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ZVRA
1D Price
Change %
ZVRA100%
+4.73%
KALV - ZVRA
37%
Loosely correlated
+0.85%
ACLX - ZVRA
37%
Loosely correlated
+3.44%
COGT - ZVRA
37%
Loosely correlated
+6.85%
IMTX - ZVRA
36%
Loosely correlated
+7.67%
ERAS - ZVRA
34%
Loosely correlated
+13.62%
More